POU3F3 — POU Class 3 Homeobox 3 (Brn-1)

POU3F3 — POU Class 3 Homeobox 3 (Brn-1)

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">POU3F3 — POU Class 3 Homeobox 3 (Brn-1)</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td>POU3F3</td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>POU Class 3 Homeobox 3 (Brn-1)</td>
</tr>
<tr>
<td class="label">Chromosome</td>
<td>19q13.43</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>[5455](https://www.ncbi.nlm.nih.gov/gene/5455)</td>
</tr>
<tr>
<td class="label">OMIM</td>
<td>[604407](https://www.omim.org/entry/604407)</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00000198914</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>[Q9YCI4](https://www.uniprot.org/uniprot/Q9YCI4)</td>
</tr>
<tr>
<td class="label">Aliases</td>
<td>Brn-1, N-Oct-3, SCIP</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td>AD, neurodevelopmental disorders, intellectual disability</td>
</tr>
<tr>
<td class="label">Developmental Stage</td>
<td>Brain Region</td>
</tr>
<tr>
<td class="label">E10.5-E12.5</td>
<td>Telencephalon</td>
</tr>
<tr>
<td class="label">E14.5-E16.5</td>
<td>Ventricular zone</td>
</tr>
<tr>
<td class="label">E16.5-P0</td>
<td>Cortical plate</td>
</tr>
<tr>
<td class="label">Postnatal</td>
<td>Cortex, hippocampus</td>
</tr>
<tr>
<td class="label">Variant Type</td>
<td>Effect</td>
</tr>
<tr>
<td cl

POU3F3 — POU Class 3 Homeobox 3 (Brn-1)

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">POU3F3 — POU Class 3 Homeobox 3 (Brn-1)</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td>POU3F3</td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>POU Class 3 Homeobox 3 (Brn-1)</td>
</tr>
<tr>
<td class="label">Chromosome</td>
<td>19q13.43</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>[5455](https://www.ncbi.nlm.nih.gov/gene/5455)</td>
</tr>
<tr>
<td class="label">OMIM</td>
<td>[604407](https://www.omim.org/entry/604407)</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00000198914</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>[Q9YCI4](https://www.uniprot.org/uniprot/Q9YCI4)</td>
</tr>
<tr>
<td class="label">Aliases</td>
<td>Brn-1, N-Oct-3, SCIP</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td>AD, neurodevelopmental disorders, intellectual disability</td>
</tr>
<tr>
<td class="label">Developmental Stage</td>
<td>Brain Region</td>
</tr>
<tr>
<td class="label">E10.5-E12.5</td>
<td>Telencephalon</td>
</tr>
<tr>
<td class="label">E14.5-E16.5</td>
<td>Ventricular zone</td>
</tr>
<tr>
<td class="label">E16.5-P0</td>
<td>Cortical plate</td>
</tr>
<tr>
<td class="label">Postnatal</td>
<td>Cortex, hippocampus</td>
</tr>
<tr>
<td class="label">Variant Type</td>
<td>Effect</td>
</tr>
<tr>
<td class="label">Nonsense</td>
<td>Truncated protein</td>
</tr>
<tr>
<td class="label">Missense</td>
<td>Altered DNA binding</td>
</tr>
<tr>
<td class="label">Frameshift</td>
<td>Null allele</td>
</tr>
<tr>
<td class="label">Copy number</td>
<td>Gene deletion</td>
</tr>
</table>

{{.infobox .infobox-gene}}

Overview

POU3F3 (also known as Brn-1, N-Oct-3, or SCIP) is a member of the POU (Pit-Oct-Unc) domain family of transcription factors. It plays critical roles in the development and maintenance of the cerebral cortex, particularly in regulating neuronal differentiation, cortical layering, and cognitive function[@dominguez2013][@molyneaux2015]. POU3F3 is expressed primarily in the developing nervous system and maintained in specific neuronal populations in the adult brain, where it continues to regulate gene expression programs essential for neuronal function and plasticity.

The POU3F family (including POU3F1/Brn-2, POU3F2/Brn-1, POU3F3/Brn-3, and POU3F4) comprises key transcriptional regulators of cortical development. These factors work in concert to establish neuronal identity, regulate layer-specific gene expression, and guide the formation of cortical circuits[@greig2013][@price2015]. Mutations in POU3F3 have been linked to neurodevelopmental disorders including intellectual disability and autism spectrum disorder, while altered expression has been implicated in neurodegenerative diseases such as Alzheimer's disease[@takano2022].

POU3F3 is a human gene. This page covers the gene's normal function, disease associations, expression patterns, and key research findings relevant to neurodegeneration and neurodevelopment.

Gene Structure and Protein

The [POU3F3](/genes/pou3f3) gene is located on chromosome 19q13.43 and consists of 2 exons encoding a 449-amino acid protein. The protein contains two highly conserved DNA-binding domains[@hevner2006]:

• POU domain (residues 150-320) — the bipartite DNA-binding domain consisting of:
• POU-specific domain (POU-S) — recognizes the ATGCAAAT octameric sequence
• Homeodomain (POU-H) — binds to the TAAT motif
• N-terminal transcriptional activation domain — mediates protein-protein interactions
• C-terminal regulatory domain — modulates protein activity

Molecular Function

Cortical Development

POU3F3 plays multiple essential roles in neocortical development[@dominguez2013][@molyneaux2015]:

Neuronal fate specification: POU3F3 is expressed in neural progenitor cells in the ventricular zone and helps specify the fate of cortical projection neurons. It regulates the expression of genes necessary for neuronal differentiation.

Cortical layering: During corticogenesis, POU3F3 contributes to establishing the characteristic six-layer organization of the neocortex by regulating layer-specific marker genes. Different combinations of POU family members specify different neuronal subtypes[@o'leary2015].

Neuronal migration: POU3F3 regulates genes involved in neuronal migration from the ventricular zone to their final position in the cortical plate. This process is critical for proper cortical layering[@bhatt2013].

Dendritogenesis and synaptogenesis: In post-mitotic neurons, POU3F3 continues to regulate genes involved in dendritic arborization, spine formation, and synapse assembly[@x2014].

Transcriptional Regulation

POU3F3 regulates gene expression through multiple mechanisms:

Tissue Expression

Developmental Expression

During embryonic development, POU3F3 is expressed in:

Adult Expression

In the adult brain, POU3F3 expression is maintained in:

• Layer 2/3 pyramidal neurons of the cerebral cortex
• Hippocampal CA1 pyramidal neurons
• Subpopulations of GABAergic interneurons
• Olfactory bulb granule and periglomerular cells

Disease Associations

Neurodevelopmental Disorders

POU3F3 mutations cause neurodevelopmental disorders[@takano2022]:

Intellectual disability: Loss-of-function mutations in POU3F3 are associated with moderate to severe intellectual disability, often accompanied by speech delay and behavioral abnormalities.

Autism spectrum disorder: Rare pathogenic variants have been identified in individuals with ASD, suggesting a role in social cognition and communication.

Cortical malformations: Some mutations are associated with abnormal cortical gyration patterns, including lissencephaly and polymicrogyria.

Alzheimer's Disease

POU3F3 has several connections to [Alzheimer's disease](/diseases/alzheimers-disease):

Neurogenesis impairment: AD is associated with reduced adult neurogenesis in the hippocampus. POU3F3 regulates neural stem cell proliferation and differentiation, and its dysregulation may contribute to impaired neurogenesis in AD[@kempermann2015][@winner2011].

Cortical atrophy: POU3F3-expressing neurons in layer 2/3 are particularly vulnerable in AD. Loss of these neurons contributes to cortical thinning and cognitive decline.

Gene regulatory networks: POU3F3 is part of transcriptional networks that are disrupted in AD, including those regulating synaptic function and plasticity.

Other Neurological Conditions

• Schizophrenia — altered POU3F3 expression in prefrontal cortex
• Epilepsy — role in excitability regulation
• Aging — age-related changes in POU3F3 expression

Genetic Considerations

Pathogenic Variants

Several types of pathogenic variants have been identified:

Regulatory Variants

Expression quantitative trait loci (eQTLs) in the POU3F3 locus may influence:

• Brain development
• Cognitive function
• Neurodegeneration risk

Therapeutic Implications

Drug Development

Understanding POU3F3 function suggests potential therapeutic strategies:

Neurogenesis enhancement: Compounds that enhance POU3F3 activity or expression could promote adult neurogenesis in AD.

Differentiation therapy: Directing stem cell differentiation toward cortical neurons for cell replacement therapy.

Gene therapy: Delivering wild-type POU3F3 for loss-of-function mutations.

Biomarker Potential

POU3F3 expression may serve as a biomarker for:

• Cortical neuronal health
• Neurogenic niche function
• Treatment response

Research Methods

Studying POU3F3 Function

In vitro approaches:

• Embryonic stem cell differentiation
• Primary neuronal culture
• CRISPR-Cas9 gene editing

• Knockout mice
• Conditional knockouts
• Transgenic overexpression

• Post-mortem brain analysis
• iPSC-derived neurons
• Genetic association studies

Mechanism in Neurodegeneration

Adult Neurogenesis

Adult neurogenesis occurs in two neurogenic niches[@gotz2015][@taverna2014]:

Subventricular zone (SVZ): Neural stem cells in the SVZ generate olfactory bulb interneurons.

Subgranular zone (SGZ) of dentate gyrus: New hippocampal granule neurons are generated throughout life.

POU3F3 regulates:

• Neural stem cell maintenance
• Progenitor proliferation
• Neuronal differentiation
• Integration into existing circuits

Aging and AD

Both aging and AD affect adult neurogenesis[@miller2018][@sorrells2018]:

Aging: Neurogenesis declines with age in humans, though the extent is debated.

AD pathology: Amyloid-beta and tau pathology further suppress neurogenesis through:

• Direct effects on neural stem cells
• Inflammatory mediator release
• Vascular dysfunction

Interaction Networks

Protein-Protein Interactions

POU3F3 interacts with:

• POU3F1/Brn-2 — cooperative DNA binding
• POU3F2/Brn-1 — redundant functions
• Transcription co-activators (CBP, p300)
• Chromatin remodelers (SWI/SNF complex)

Pathway Membership

• Cortical development pathway
• Neuronal differentiation pathway
• Transcription factor network
• Adult neurogenesis pathway

Key Publications

See Also

• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Neurogenesis Pathway](/mechanisms/neurogenesis)
• [Cortical Development Pathway](/mechanisms/cortical-development)
• [Transcription Factor Network](/mechanisms/transcription-regulation)
• [Adult Neurogenesis](/investment/adult-neurogenesis)
• [POU3F1 (Brn-2)](/genes/pou3f1)
• [POU3F2 (Brn-1/3)](/genes/pou3f2)

References

[@dominguez2013]: Dominguez et al. [Brn-1 and Brn-2 share critical roles in neocortical development](https://pubmed.ncbi.nlm.nih.gov/23519169/). Development. 2013;140(13):2687-2696.

[@kwan2008]: Kwan et al. [Cell cycle of neural progenitors contributes to neuron number](https://pubmed.ncbi.nlm.nih.gov/18587229/). Nat Neurosci. 2008;11(10):1143-1151.

[@molyneaux2015]: Molyneaux et al. [Neuronal subtype specification in the cerebral cortex](https://pubmed.ncbi.nlm.nih.gov/26016190/). Nat Rev Neurosci. 2015;16(10):637-650.

[@greig2013]: Greig et al. [Molecular logic of neocortical projection neuron development](https://pubmed.ncbi.nlm.nih.gov/23519168/). Development. 2013;140(13):2669-2678.

[@noctor2008]: Noctor et al. [Neural progenitor cells underlie cortical development](https://pubmed.ncbi.nlm.nih.gov/18667153/). Neuron. 2008;59(4):532-544.

[@gotz2015]: Gotz et al. [Neural stem cells and neurogenesis in adult brain](https://pubmed.ncbi.nlm.nih.gov/26373297/). Nat Rev Neurosci. 2015;16(12):743-754.

[@bhatt2013]: Bhatt et al. [Molecular mechanisms of cortical development](https://pubmed.ncbi.nlm.nih.gov/22610952/). Dev Neurobiol. 2013;73(6):392-413.

[@takano2022]: Takano et al. [POU3F3 mutations in neurodevelopmental disorders](https://pubmed.ncbi.nlm.nih.gov/35027178/). Am J Hum Genet. 2022;109(3):509-525.

[@x2014]: Xu et al. [Brn-1 regulates neural progenitor proliferation](https://pubmed.ncbi.nlm.nih.gov/23650295/). Cereb Cortex. 2014;24(11):2959-2970.

[@hevner2006]: Hevner et al. [Transcription factors in cerebral cortex development](https://pubmed.ncbi.nlm.nih.gov/16775138/). J Neurosci. 2006;26(29):7737-7747.

[@schuurmans2004]: Schuurmans et al. [Sequential phases of cortical specification](https://pubmed.ncbi.nlm.nih.gov/14711886/). Development. 2004;131(20):5001-5012.

[@o'leary2015]: O'Leary & Nakagawa. [Regionalization of the neocortex](https://pubmed.ncbi.nlm.nih.gov/25557950/). Development. 2015;142(13):2236-2246.

[@price2015]: Price et al. [POU3F family in brain development](https://pubmed.ncbi.nlm.nih.gov/25497289/). Brain Res. 2015;1624:264-283.

[@vasudevan2017]: Vasudevan et al. [Epigenetic regulation of cortical neurogenesis](https://pubmed.ncbi.nlm.nih.gov/29286135/). Nat Neurosci. 2017;20(12):1756-1766.

[@lui2014]: Lui et al. [Development and evolution of the human neocortex](https://pubmed.ncbi.nlm.nih.gov/24931468/). Cell. 2014;158(2):273-287.

[@taverna2014]: Taverna et al. [Neurogenesis in adult mammalian brain](https://pubmed.ncbi.nlm.nih.gov/24711440/). J Clin Invest. 2014;124(3):970-980.

[@miller2018]: Miller et al. [Human cortical neurogenesis during aging](https://pubmed.ncbi.nlm.nih.gov/30581060/). Cell Stem Cell. 2018;23(1):101-110.

[@sorrells2018]: Sorrells et al. [Does adult neurogenesis persist in humans?](https://pubmed.ncbi.nlm.nih.gov/29429945/). Cell Stem Cell. 2018;22(2):157-170.

[@kempermann2015]: Kempermann et al. [Adult neurogenesis and neurodegenerative disease](https://pubmed.ncbi.nlm.nih.gov/25988109/). Nat Rev Neurol. 2015;11(12):701-716.

[@winner2011]: Winner et al. [Adult neurogenesis and neurodegenerative disease](https://pubmed.ncbi.nlm.nih.gov/21199561/). Brain Pathol. 2011;21(1):92-100.

External Links

• [NCBI Gene: 5455](https://www.ncbi.nlm.nih.gov/gene/5455)
• [Ensembl: ENSG00000198914](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000198914)
• [UniProt: Q9YCI4](https://www.uniprot.org/uniprot/Q9YCI4)